GGrantIndex
Sort

85,873 grants matching alzheimers

Effects of Resonance-Frequency Breathing on Preclinical Alzheimer’s Disease Biomarkers and Cognition

$998,359
Mara Mather · University Of Southern California · R01 · FY2025 · AG

Novel mechanisms of NSAID action in Alzheimer disease

$998,120
University Of California San Diego · P01 · FY2002 · AG

Technology-Enabled Financial Planning for Caregivers and Clients with Reduced Capacity

$998,064
John E Porterfield · Bridgesource Medical Corporation · R44 · FY2023 · AG

Mitochondrial Integrated Stress Response in Neurological Diseases

$998,006
Giovanni Manfredi · Weill Medical Coll Of Cornell Univ · R35 · FY2021 · NS

Glutamate receptors and human neurological disease

$997,882
Stephen F. Traynelis · Emory University · R35 · FY2025 · NS

Sequence-based Discovery of AD Risk & Protective Alleles

$997,756
Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston · U01 · FY2014 · AG

Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)

$997,731
Paul B Rosenberg · Johns Hopkins University · R01 · FY2020 · AG

Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)

$997,674
Paul B Rosenberg · Johns Hopkins University · R01 · FY2018 · AG

Alzheimer's Disease Core Center

$997,485
Northwestern University · P30 · FY2002 · AG

Core B-Clinical Core

$997,474
David Sultzer · University Of California-Irvine · P30 · FY2023 · AG

Research Centers Collaborative Network Renewal

$997,280
Stephen B Kritchevsky · Wake Forest University Health Sciences · U24 · FY2024 · AG

Research Centers Collaborative Network Renewal

$997,280
Stephen B Kritchevsky · Wake Forest University Health Sciences · U24 · FY2022 · AG

Research Centers Collaborative Network Renewal

$997,278
Stephen B Kritchevsky · Wake Forest University Health Sciences · U24 · FY2025 · AG

An H/F/X/Y Fast-MAS NMR Probe Particularly for Alzheimer's and Cancer Research

$997,231
Francis David Doty · Doty Scientific, Inc. · R44 · FY2020 · GM

Aging, Health, and Care: the Geography of Residential Proximity Between Parents and Adult Children

$997,190
H Elizabeth Peters · Urban Institute · RF1 · FY2021 · AG

Clinical Core

$997,140
Douglas R Galasko · University Of California, San Diego · P30 · FY2023 · AG

Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)

$996,923
Paul B Rosenberg · Johns Hopkins University · R01 · FY2017 · AG

Recharge Behavioral Therapy for caregivers of individuals with Alzheimer's Disease

$996,805
Bruno Kajiyama · Photozig, Inc. · R44 · FY2025 · AG

Optimization and Validation of an Indicator Cell Assay for Blood-Based Diagnosis of Alzheimer's Disease

$996,801
Jennifer Joy Smith · Precyte, Inc. · R44 · FY2018 · AG

Preeclampsia and the Brain: Small vessel disease and cognitive function in early midlife

$996,791
Janet M Catov · Magee-Women'S Res Inst And Foundation · R01 · FY2024 · AG

Clinical Core

$996,758
Robert A Sweet · University Of Pittsburgh At Pittsburgh · P30 · FY2024 · AG

Clinical Core

$996,615
Aimee Pierce · Oregon Health & Science University · P30 · FY2024 · AG

Clinical Core

$996,613
Aimee Pierce · Oregon Health & Science University · P30 · FY2021 · AG

Clinical Core

$996,613
Aimee Pierce · Oregon Health & Science University · P30 · FY2023 · AG

ALCOHOL USE AS A MODERATING FACTOR IN SEROTONERGIC NEURODEGENERATION IN THE EARLY STAGES OF ALZHEIMER'S DISEASE

$996,586
University Of Florida · · FY2025 · Defense Health Agency